On August 18, 2026, a clinical trial update was recorded for a study involving vasopressin, registered as NCT05801224. The trial is titled "Vascular ARDS Recruitment After Inhaled Nitric Oxide." Its current status is listed as recruiting. The trial phase is designated NA. No results have been posted for this study as of this update. The update reflects the trial's recruitment status only and does not include outcome data or findings. Vasopressin is an approved compound, and this listing pertains to its investigation within the context of this specific trial. Readers should note that a recruiting status indicates the study is actively enrolling participants but has not yet reported conclusions. No efficacy or safety results are described in this update. Further details on trial design, eligibility, and objectives can be found in the official registry entry. For more background on vasopressin, readers can consult the compound overview.
Vasopressin Trial NCT05801224 Recruiting as of Aug 2026
See the full vasopressin overview
Source: https://clinicaltrials.gov/study/NCT05801224